1. Сказываева Е.В., Ситкин С.И., Бакулин И.Г., Авалуева Е.Б., Журавлева М.С., Скалинская М.И. Дивертикулярная болезнь толстой кишки: этиопатогенез, диагностика, лечение и профилактика. –М.: Прима Принт. 2022. -73с. 2. Yamamichi N. etal. Trend and Risk Factors of Diverticulosis in Japan: Age, Gender, and Lifestyle/Metabolic-Related Factors May Cooperatively Affect on the Colorectal Diverticula Formation. PLOS ONE 10, e0 23688 (2015). 3. Gralnek I.M., Neeman Z., Strate L.L. Acute Lower Gastrointestinal Bleeding. N Engl J Med. 2017 Mar 16; 376(11): 1054-1063. 4. Boostrom S.Y., Wolff B.G., Cima R.R. et al. Uncomplicated diverticulitis, more complicated than we thought. J Gastrointest Surg. 2012 Sep; 16(9): 1744-1749. 5. Bharucha A.E., Parthasarathy G., Ditah I. et al. Temporal Trends in the Incidence and Natural History of Diverticulitis: A Population-Based Study. Am J Gastroenterol. 2015 Nov; 110(11): 1589- 1596. 6. Lisa L. Strate, Arden M. Morris. Epidemiology, Pathophysiology, and Treatment of Diverticulitis Gastroenterology. 2019 Apr; 156(5): 1282- 1298.e1. doi: 10.1053/j.gastro.2018.12.033. 7. Tursi A. Current and Evolving Concepts on the Pathogenesis of Diverticular Disease. J Gastrointestin Liver Dis. 2019; 28: 225-223. doi:10.15403/ JGLD-184. 8. Strate L.L., Erichsen R., Baron J.A. et al. Heritability and familial aggregation of diverticular disease: a population-based study of twins and siblings. Gastroenterology, 2013; 144: 736-742. doi:10.1053/j. gastro.2012.12.030. 9. Granlund J., Svensson T., Olén O. et al. The genetic infl uence on diverticular disease- a twin study. Aliment Pharmacol Ther. 2012; 35: 1103-1107. doi:10.1111/j.1365-2036.2012.05069. 10. Sigurdsson S., Alexandersson, K.F., Sulem P. et al. Sequence variant in ARHGAP15, COLQ and FAM155A associate with diverticular disease and diverticulitis. Nat Commun. 2017; 8: 15789. doi:10.1038/ncomms15789. 11. Maguire L.H., Handelman S.K., Du X. et al. Genome-wide association analyses identify 39 new susceptibility loci for diverticular disease. Nat Genet. 2018; 50: 1359-1365. doi:10.1038/s41588-018- 0203-z. 12. Schafmayer C., Harrison J.W., Buch S. et al. Genome-wide association analysis of diverticular disease points towards neuromuscular, connective tissue and epithelial pathomechanisms. Gut. 2019; 68: 854-865. doi:10.1136/gutjnl-2018-317619. 13. Painter N.S. Diverticular disease of the colon. Br Med J. 1968; 3: 475-479. 14. Golder M., Burleigh D.E., Ghali L. et al. Longitudinal muscle shows abnormal relaxation responses to nitric oxide and contains altered levels of NOS1 and elastin in uncomplicated diverticular disease. Colorectal Dis. 2007; 9: 218-228. doi:10.1111/j.1463-1318.2006.01160.x. 15. Parks T.G., Connell A.M. Motility studies in diverticular disease of the colon. Gut. 1969; 10: 534- 542.doi: 10.1136/gut.10.7.534. 16. Bassotti G., Battaglia E., Bellone G. et al. Interstitial cells of Cajal, enteric nerves, and glial cells in colonic diverticular disease. J Clin Pathol. 2005; 58: 973-977.doi:10.1136/jcp.2005.026112. 36 17. Rao M., Rastelli D., Dong L. et al. Enteric glia regulate gastrointestinal motility but are not required for maintenance of the epithelium in mice. Gastroenterology. 2017; 153: 1068-1081. e7.doi:10.1053/j.gastro.2017.07.002. 18. Böttner M., Barrenschee M., Hellwig I., et al. The enteric serotonergic system is altered in patients with iverticular disease.Gut. 2013; 62: 1753-1762. doi:10.1136/gutjnl-2012-302660. 19. Egger B., Peter M.K., Candinas D. Persistent symptoms after elective sigmoid resection for diverticulitis. Dis Colon Rectum. 2008; 51: 1044-104. 20. Humes D.J., Simpson J., Smith J. et al. Visceral hypersensitivity in symptomatic diverticular disease and the role of neuropeptides and lowgrade infl ammation. Neurogastroenterol Motil. 2012; 24: 318-e163. 21. Bartho L., Benko R., Holzer-Petsche U. et al. Role of extrinsic afferent neurons in strointestinal motility. Eur Rev Med Pharmacol Sci. 2008; 12 (Suppl 1): 21-31. 22. Bartho L., Benko R., Holzer-Petsche U. et al. Role of extrinsic afferent neurons in strointestinal motility. Eur Rev Med Pharmacol Sci. 2008; 12 (Suppl 1): 21-31. 23. Clemens C.H., Samsom M., Roelofs J. et al. Colorectal visceral perception in diverticular disease. Gut .2004; 53: 717-722. Clin Gastroenterol Hepatol. 2019 Jul; 17(8): 1448-1456.e17. 24. Pauza A.G., Rysevaite-Kyguoliene K., Malinauskas M. et al. Alterations in enteric calcitonin gene-related peptide in patients with colonic diverticular disease: CGRP in diverticular disease.Auton Neurosci. 2019; 216: 63-71. 25. Spiller R.C., Humes D.J., Campbell E. et al. The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity nd consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease. Aliment Pharmacol Ther. 2010; 32: 811-820. 26. Humes D.J., Simpson J., Neal K.R. et al. Psychological and colonic factors in painful diverticulosis. Br J Surg. 2008; 95: 195-198. 27. Painter N.S., Burkitt D.P. Diverticular disease of the colon: a deficiency disease of western civilization. Br Med J. 1971; 2: 450-454. 28. Aldoori W.H., Giovannucci E.L., Rockett H.R., et al. A prospective study of dietary fi ber types and symptomatic diverticular disease in men. J Nutr. 1998; 128: 714-719. 29. Crowe F.L., Appleby P.N., Allen N.E., et al. Diet and risk of diverticular disease in Oxford cohort of European Prospective Investigation into Cancer and Nutrition (EPIC): prospective study of British vegetarians and non-vegetarians. BMJ. 2011; 343. 30. Aune D., Sen A., Norat T., Riboli E. Dietary fi bre intake and the risk of diverticular disease: a systematic review and meta-analysis of prospective studies. Eur J Nutr. 2020 Mar; 59(2): 421-432. doi: 10.1007/s00394-019- 01967-w. Epub 2019 Apr 29. PMID: 31037341; PMCID: PMC7058673. 31. Strate L.L., Liu Y.L., Syngal S. et al. Nut, corn, and popcorn consumption and the incidence of diverticular disease. JAMA 2008; 300: 907-914. 32. Maguire L.H., Song M., Strate L.E. et al. Higher serum levels of vitamin D are associated with a reduced risk of diverticulitis. Clin Gastroenterol Hepatol. 2013; 11: 1631-1635. Cao Y., Strate L.L., Keeley B.R. et al. Meat intake and risk of diverticulitis among men. Gut. 2018; 67: 466-472. 33. Maguire L.H., Song M., Strate L.L. et al. Association of geographic and seasonal variation with diverticulitis admissions. JAMA Surg. 2015; 150: 74-77. 34. Tursi A. Current and Evolving Concepts on the Pathogenesis of Diverticular Disease. J Gastrointestin Liver Dis. 2019; 28: 225-223. doi:10.15403/ JGLD-184. 35. Maguire L.H., Song M., Strate L.L. et al. Association of geographic and seasonal variation with diverticulitis admissions. JAMA Surg. 2015; 150: 74-77. 36. Strate L.L., Liu Y.L., Syngal S. et al. Nut, corn, and popcorn consumption and the incidence of diverticular disease. JAMA 2008; 300: 907-914. 37 37. Strate L.L., Liu Y.L., Huang E.S. et al. Use of aspirin or nonsteroidal anti-infl ammatory drugs increases risk for diverticulitis and diverticular bleeding. Gastroenterology. 2011; 140: 1427-1433. 38. Humes D.J., Fleming K.M., Spiller R.C. et al. Concurrent drug use and the risk of perforated colonic diverticular disease: a population-based case-control study. Gut. 2011; 60: 219-224. 39. Strate L.L., Modi R., Cohen E. et al. Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights. Am J Gastroenterol. 2012; 107: 1486-1493. 40. Barbara G., Cremon C., Barbaro M.R. et al. Treatment of Diverticular Disease With Aminosalicylates: The Evidence. J Clin Gastroenterol. 2016 Oct; 50 Suppl 1(): S60-63. 41. Laghi L., Mastromarino P., Elisei W. et al. Impact of treatments on fecal microbiota and fecal metabolome in symptomatic uncomplicated diverticular disease of the colon: a pilot study. J Biol Regul Homeost Agents. 2018; 32: 1421-1432. 42. Derrien M., Vaughan E.E., Plugge C.M. et al. Akkermansia uciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004; 54: 1469-1476. 43. Biagi E., Nylund L., Candela M. et al. Through ageing, and beyond: gut microbiota and infl ammatory status in seniors and centenarians. PLoS One2010;5:e10667. 44. Daniels L., Budding A.E., de Korte N. et al. Fecal microbiome analysis as a diagnostic test for diverticulitis. Eur J Clin Microbiol Infect Dis 2014; 33: 1927-1936. 45. Schieffer K.M., Sabey K., Wright J.R. et al. The microbial ecosystem distinguishes chronically diseased tissue from adjacent tissue in the sigmoid colon of chronic, recurrent diverticulitis patients. Sci Rep. 2017; 7: 8467. 46. Kvasnovsky C.L., Leong L.E.X., Choo J.M. et al. Clinical and symptom scores are signifi cantly correlated with fecal microbiota features in patients with symptomatic uncomplicated diverticular disease: a pilot study. Eur J Gastroenterol Hepatol. 2018; 30: 107-112. 47. Peery A.F., Crockett S.D., Barritt A.S. Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States. Gastroenterology. 2015 Dec; 149(7): 1731-1741.e3. 48. Everhart J.E., Ruhl C.E. Burden of digestive diseases in the United States part II: lower gastrointestinal diseases. Gastroenterology. 2009 Mar; 136(3): 741-754. 49. Tursi A. Diverticulosis today: unfashionable and still under-researched. Therap Adv Gastroenterol. 2016 Mar; 9(2): 213-228. 50. Peery A.F., Crockett S.D., Barritt A.S. Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States. Gastroenterology. 2015 Dec; 149(7): 1731-1741.e3. 51. Peery A.F. Colonic Diverticula and Diverticular Disease: 10 Facts Clinicians Should Know. N C Med J. 2016 May-Jun; 77(3): 220-222. 52. Shahedi K. et al. Long-term Risk of Acute Diverticulitis Among Patients With Incidental Diverticulosis Found During Colonoscopy. Clinical Gastroenterology and Hepatology 11, 1609-1613 (2013). 53. Jeyarajah S. et al. Diverticular disease hospital admissions are increasing, with poor outcomes in the elderly and emergency admissions. Alimentary Pharmacology & Therapeutics 30, 1171-1182 (2009). 54. Binda G.A. et al. Trends in hospital admission for acute diverticulitis in Italy from 2008 to 2015. Techniques in Coloproctology 22, 597–604 (2018). 55. Клинические рекомендации. – Дивертикулярная болезнь – 2021- 2022-2023 (25.06.2021) – Утверждены Минздравом РФ. 56. Schieffer K.M., Kline B.P., Yochum G.S. et al. Pathophysiology of diverticular disease. Expert Review of Gastroenterology & Hepatology 12, 683-692 (2018). 57. Strate L.L., Morris A.M. Epidemiology, Pathophysiology, and Treatment of Diverticulitis. Gastroenterology. 2019 Apr; 156(5): 1282-1298.e1. 38 58. Böhm S.K, Kruis W. Lifestyle and other risk factors for diverticulitis. Minerva Gastroenterol Dietol. 2017 Jun; 63(2): 110-118. 59. Aune D., Sen A., Leitzmann M.F. et al. Tobacco smoking and the risk of diverticular disease – a systematic review and meta-analysis of prospective studies. Colorectal Dis. 2017 Jul; 19(7): 621-633. 60. Hjern F., Johansson C., Mellgren A. et al. Diverticular disease and migration – the infl uence of acculturation to a Western lifestyle on diverticular disease. Alimentary Pharmacology and Therapeutics 23, 797-805 (2006). 61. Liu P.H., Cao Y., Keeley B.R. et al. Adherence to a Healthy Lifestyle is Associated With a Lower Risk of Diverticulitis among Men. Am J Gastroenterol. 2017 Dec; 112(12): 1868-1876. 62. Tursi A. Current and Evolving Concepts on the Pathogenesis of Diverticular Disease. J Gastrointestin Liver Dis. 2019; 28: 225-223. doi:10.15403/ JGLD-184. 63. Kechagias A., Sofi anidis A., Zografos G. et al. Index C-reactive protein predicts increased severity in acute sigmoid diverticulitis. C Ther Clin Risk Manag. 2018; 14(): 1847-1853. 64. Tursi A. Biomarkers in diverticular diseases of the colon. Dig Dis. 2012; 30(1): 12-18. 65. Tursi A., Brandimarte G., Elisei W. et al. Faecal calprotectin in colonic diverticular disease: a case-control study. Int J Colorectal Dis. 2009 Jan; 24(1): 49-55. 66. Jeger V., Pop R., Forudastan F. et al. Is there a role for procalcitonin in differentiating uncomplicated and complicated diverticulitis in order to reduce antibiotic therapy? Swiss Med Wkly. 2018 Sep 24; 148(): w14673. 67. Tursi A., Scarpignato C., Strate L.L. et al. Colonic diverticular disease // Nat Rev Dis Primers. 6(1): 20. doi:10.1038/s41572-020-0153-5. 68. Niikura R., Nagata N., Shimbo T. et al. Colonoscopy can miss diverticula of the left colon identifi ed by barium enema. World J Gastroenterol. 2013 Apr 21; 19(15): 2362-2367. 69. Andeweg C.S., Wegdam J.A., Groenewoud J., et al. Toward an evidence-based step-up approach in diagnosing diverticulitis. Scand J Gastroenterol. 2014 Jul; 49(7): 775-784. 70. Bor R., Fábián A., Szepes Z. Role of ultrasound in colorectal diseases. World J Gastroenterol. 2016 Nov 21; 22(43): 9477-9487. 71. Kruis W. et al., 2014). Kruis W., Germer C.T., Leifeld L. Diverticular disease: guidelines of the german society for gastroenterology, digestive and metabolic diseases and the german society for general and visceral surgery. German Society for Gastroenterology, Digestive and Metabolic Diseases and The German Society for General and Visceral Surgery.Digestion. 2014; 90(3): 190-207. 72. Min J.H., Kim H.C., Kim S.W. et al. The value of initial sonography compared to supplementary CT for diagnosing right-sided colonic diverticulitis. 2017 Jul; 35(7): 358-365. 73. Farag Soliman M., Wüstner M., Sturm J. et al. Primary diagnostics of acute diverticulitis of the sigmoid. Ultraschall Med. 2004 Sep; 25(5): 342-347. 74. Puylaert J.B. Ultrasound of colon diverticulitis. Dig Dis. 2012; 30(1): 56- 59. 75. Nielsen K. et al. The Limited Role of Ultrasound in the Diagnostic Process of Colonic Diverticulitis. World Journal of Surgery (2013). doi:10.1007/s00268-013-2423-9. 76. Dickerson E.C., Chong S.T., Ellis J.H. et al. Recurrence of Colonic Diverticulitis: Identifying Predictive CT Findings-Retrospective Cohort Study. Radiology. 2017 Dec; 285(3): 850-858. 77. Lembcke B.J., Strobel D., Dirks K. et al. Statement of the section internal medicine of the DEGUM – ultrasound obtains pole position for clinical imaging in acute diverticulitis, Ultraschall Med. 2015 Apr; 36(2): 191-195. 78. Mounce L.T.A., Price S., Valderas J.M. et al. Comorbid conditions delay diagnosis of colorectal cancer: a cohort study using electronic primary care records. Br J Cancer. 2017 Jun 6; 116(12): 1536- 1543. 39 79. Papi C., Ciaco A., Koch M. et al. Effi cacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre dou-ble-blind placebo-controlled trial. Aliment. Pharmacol. Ther. 9, 33-39 (1995). 80. Schieffer K.M., Sabey K., Wright J.R. et al. The microbial ecosystem distinguishes chronically diseased tissue from adjacent tissue in the sigmoid colon of chronic, recurrent diverticulitis patients. Sci Rep. 2017; 7: 8467. 81. Barbara G., Scaioli E., Barbaro M.R. et al. Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease. Gut. 2017 Jul; 66(7): 1252-1261. 82. Kurpad A.V., Shetty P.S. Effects of antimicrobial therapy on faecal bulking. Gut. 1986 Jan; 27(1): 55-58. 83. Frieri G., Pimpo M.T., Scarpignato C. Management of colonic diverticular disease. Digestion. 2006; 73 Suppl 1(): 58-66. 84. Ponziani F.R. et al., 2017) Ponziani F.R., Zocco M.A., D’Aversa F. et al. Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation. World J Gastroenterol. 2017 Jul 7; 23(25):4491-4499. 85. Gatta L. & Scarpignato C. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Alimentary Pharmacology & Therapeutics 45, 604-616 (2017). 86. Stallinger S. Et al., 2013 Stallinger S., Eller N. & Högenauer C. Non-interventional study evaluating effi cacy and tolerability of rifaximin for treatment of uncomplicated diverticular disease. Wiener klinische Wochenschrift 126, 9-14 (2013). 87. Latella G., Scarpignato C. Rifaximin in the management of colonic diverticular disease. Expert Rev Gastroenterol Hepatol. 2009 Dec; 3(6): 585-598. 88. Bianchi M., Festa V., Moretti A. et al. Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease. Aliment Pharmacol Ther. 2011 Apr; 33(8): 902-910. 89. Copaci I., Constantinescu G., Mihăilă M. et al. Effi cacy of Rifaximin-a vs Dietary Fiber on the Evolution of Uncomplicated Colonic Diverticular Disease. Surg Gastroenterol Oncol. 2019; 24: 233-240. DOI: 10.21614/ sgo-24-5-233. 90. Moniuszko A., Rydzewska G. The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a ―real-life‖ study. Prz Gastroenterol. 2017; 12(2): 145-151. 91. Picchio M., Elisei W., Brandimarte G. et al. Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials. J Clin Gastroenterol. 2016 Oct; 50 Suppl 1: S64- 69. doi: 10.1097/MCG.0000000000000669. 92. Krokowicz et al. Microencapsulated sodium butyrate administered to patients with diverticulosis decreaseincidence of diverticulitis – a prospective randimized study. Int J Colorectal Dis. (2014) 29: 387- 393. 93. Scarpignato C., Bertelé A., Tursi A. Probiotics for the Treatment of Symptomatic Uncomplicated Diverticular Disease: Rationale and Current Evidence. J Clin Gastroenterol. 2016 Oct; 50 Suppl 1: S70- 73. 94. Lahner E., Bellisario C., Hassan C. et al. Probiotics in the Treatment of Diverticular Disease. A Systematic Review. J Gastrointestin Liver Dis. 2016 Mar; 25(1): 79-86. 95. Tursi A., G Brandimart G., Elisei W et al. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease-a double-blind, randomised, placebo-controlled study. Aliment Pharmacol Ther. 2013 Oct;38(7):741-51. 40 96. Sánchez-Velázquez P., Grande L. & Pera M. Outpatient treatment of uncomplicated diverticulitis. European Journal of Gastroenterology & Hepatology 28, 622-627 (2016). 97. Cirocchi R., Randolph J.J., Binda G.A. Is the outpatient management of acute diverticulitis safe and effective? A systematic review and meta-analysis. Tech Coloproctol. 2019 Feb; 23(2): 87-100. 98. Stam M.A., Draaisma W.A., van de Wall B.J. et al. An unrestricted diet for uncomplicated diverticulitis is safe: results of a prospective diverticulitis diet study. Colorectal Dis. 2017 Apr; 19(4): 372-377. 99. Van de Wall B.J., Draaisma W.A., van Iersel J.J. et al. Dietary restrictions for acute diverticulitis: evidence-based or expert opinion? Int J Colorectal Dis. 2013 Sep; 28(9): 1287-1293. 100. Chabok A., Påhlman L., Hjern F. et al. Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. Br J Surg. 2012 Apr; 99(4): 532-539.2013. 101. Daniels L., Ünlü Ç., de Korte N. et al. Randomized clinical trial of observational versus antibiotic treatment for a fi rst episode of CT-proven uncomplicated acute diverticulitis. Dutch Diverticular Disease (3D) Collaborative Study Group.Br J Surg. 2017 Jan; 104(1): 52-61. 102. Tandon A., Fretwell V.L., Nunes Q.M. et al. Antibiotics versus no antibiotics in the treatment of acute uncomplicated diverticulitis – a systematic review and meta-analysis. Colorectal Dis. 2018 Jan; 11. 103. Emile S.H., Elfeki H., Sakr A. et al. Management of acute uncomplicated diverticulitis without antibiotics: a systematic review, meta-analysis, and meta-regression of predictors of treatment. Tech Coloproctol. 2018 Jul; 22(7): 499-509. 104. Van Dijk S.T. с соавт. (2018) Van Dijk S.T., Daniels L., Ünlü Ç. et al. Long-Term Effects of Omitting Antibiotics in Uncomplicated Acute Diverticulitis. Dutch Diverticular Disease (3D) Collaborative Study Group.Am J Gastroenterol. 2018 Jul; 113(7): 1045-1052. 105. Slim K., Joris J., Beyer-Berjot L. The end of antibiotics in the management of uncomplicated acute diverticulitis. J Visc Surg. 2019 Oct; 156(5): 373-375. 106. Stollman N., Smalley W., Hirano I. et al. American Gastroenterological Association Institute Guideline on the Management of Acute Diverticulitis. Gastroenterology. 2015; 149: 1944-1949. 107. Rottier S.J., van Dijk S.T., Ünlü Ç. et al. Complicated Disease Course in Initially Computed Tomography-Proven Uncomplicated Acute Diverticulitis. Surg Infect (Larchmt). 2019 Sep; 20(6): 453- 459. 108. Bolkenstein H.E., Consten E.C.J., van der Palen J. et al. Long-term Outcome of Surgery Versus Conservative Management for Recurrent and Ongoing Complaints After an Episode of Diverticulitis: 5- year Follow-up Results of a Multicenter Randomized Controlled Trial (DI-RECT-Trial). Dutch Diverticular Disease (3D) Collaborative Study Group. Ann Surg. 2019 Apr; 269(4): 612-620. 109. Jaung R. et al., 2017 Jaung R., Kularatna M., Robertson J.P. et al. Uncomplicated Acute Diverticulitis: Identifying Risk Factors for Severe Outcomes. World J Surg. 2017 Sep; 41(9): 2258-2265. 110. Shabanzadeh D.M., Wille-Jørgensen P. Antibiotics for uncomplicated diverticulitis. Cochrane Database Syst Rev. 2012 Nov 14; 11(): CD009092. 111. Schug-Pass C., Geers P., Hügel O. et al. Prospective randomized trial comparing short-term antibiotic therapy versus standard therapy for acute uncomplicated sigmoid diverticulitis. Int J Colorectal Dis. 2010 Jun; 25(6): 751-759. 112. Evans J., Kozol R., Frederick W. Does a 48-hour rule predict outcomes in patients with acute sigmoid diverticulitis? J Gastrointest Surg. 2008 Mar; 12(3): 577-582. 113. Gregersen R, Mortensen LQ, Burcharth J, Pommergaard HC, Rosenberg J. Treatment of patients with acute colonic diverticulitis complicated by abscess formation: A systematic review. Int J Surg. 2016 Nov; 35: 201-208. doi: 10.1016/j.ijsu.2016.10.006. Epub 2016 Oct 11. 114. Young-Fadok T.M. Diverticulitis. N Engl J Med. 2018 Oct 25; 379(17): 1635-1642. 41 115. Galetin T., Galetin A., Vestweber K.H., Rink A.D. Systematic review and comparison of national and international guidelines on diverticular disease. Int J Colorectal Dis. 2018 Mar; 33(3): 261-272. doi: 10.1007/s00384-017-2960-z. Epub 2018 Jan 18. 116. Cirocchi R, Afshar S, Di Saverio S, et al. A historical review of surgery for peritonitis secondary to acute colonic diverticulitis: from Lockhart-Mummery to evidence-based medicine. World J Emerg Surg. 2017; 12: 14. Published 2017 Mar 9. doi: 10.1186/s13017-017-0120-y. 117. Biondo S. The diminishing role of surgery for acute diverticulitis. Br J Surg. 2019 Mar; 106(4): 308-309. 118. Strate L.L., Morris A.M. Epidemiology, Pathophysiology, and Treatment of Diverticulitis. Gastroenterology. 2019 Apr; 156(5): 1282-1298.e1. 119. Stollman N., Magowan S., Shanahan F. et al. A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial. J Clin Gastroenterol. 2013 Aug; 47(7): 621-629. 120. Khan R.M.A., Ali B., Hajibandeh S. et al. Effect of mesalazine on recurrence of diverticulitis in patients with symptomatic uncomplicated diverticular disease: a meta-analysis with trial sequential analysis of randomized controlled trials. Colorectal Dis. 2018 Jun; 20(6): 469-478. 121. Nespoli L., Lo Bianco G., Uggeri F. et al. Effect of oral mesalamine on infl ammatory response in acute uncomplicated diverticulitis. World J Gastroenterol. 2015 Jul 21; 21(27): 8366-8372. 122. Lanas A., Ponce J., Bignamini A. et al. One year intermittent rifaximin plus fi bre supplementation vs. fi bre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study. Dig Liver Dis. 2013 Feb; 45(2): 104-109. 123. Festa V., Spila Alegiani S., Chiesara F. et al. Retrospective comparison of long-term tenday/month rifaximin or mesalazine in prevention of relapse in acute diverticulitis. Eur Rev Med Pharmacol Sci. 2017 Mar; 21(6): 1397-1404. 124. Tursi A., Brandimarte G., Daffi nà R. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis. 2002 Jul; 34(7): 510-515. 125. Парфенов А.И., Крумс Л.М., Павлов М.В. Дивертикулы тонкой кишки. Терапевтический архив. 2019; 91 (2): 4-8. DOI: 10.26442/00403660.2019.02.000080; 30. 126. Инновации в питании для взрослых : Ежегодное издание с каталогом. Выпуск 1 / Под ред. В.А. Тутельяна, Д.Б. Никитюка, А.В. Погожевой, А.Е. Шестопалова, Т.С. Поповой. – Москва : ООО «Медицинское информационное агентсво», 2021. – 176 с. 127. Клиническая фармакология и фармакотерапия / под ред. С.В. Оковитого, А.Н. Куликова. – Москва : ГЭОТАР-Медиа, 2022. – 848 с. – doi: 10.33029/9704-6291-1-PHA-2022-1-848. 128. Смолянский Б.Л., Лифляндский В.Г. Диетология. Новейший справочник для врачей. М.: ЭКСМО. 2003; 816 c. 129. Маев И.В., Дичева Д.Т., Андреев Д.Н., Лебедева Е.Г., Баева Т.А. Дивертикулярная болезнь толстой кишки. – М., 2015 – 22 с. 130. Руководство по гастроэнтерологии / Под ред. Ф. И. Комарова, С. И. Рапопорта. — М.: Медицинское информационное агентство, 2010. — 864 с. 131. Пищевые волокна – важный компонент здорового питания. [Электронный ресурс] Режим доступа:http://25.rospotrebnadzor.ru/338/- /asset_publisher/rlD3/content/%D0%BF%D0%B8%D1%89%D0%B5%D0%B2%D1%8B%D0%B5- %D0%B2%D0%BE%D0%BB%D0%BE%D0%BA%D0%BD%D0%B0-%E2%80%93- %D0%B2%D0%B0%D0%B6%D0%BD%D1%8B%D0%B8- %D0%BA%D0%BE%D0%BC%D0%BF%D0%BE%D0%BD%D0%B5%D0%BD%D1%82- %D0%B7%D0%B4%D0%BE%D1%80%D0%BE%D0%B2%D0%BE%D0%B3%D0%BE- %D0%BF%D0%B8%D1%82%D0%B0%D0%BD%D0%B8%D1%8F 42 132. Справочник по диетологии / под ред. В. А. Тутельяна, М. А. Самсонова. - 3. изд., перераб. и доп. - Москва : Медицина, 2002. - 541 с. 133. Буторова Л.И. Дивертикулярная болезнь толстой кишки: клинические формы, диагностика и лечение: пособие для врачей / Л.И. Буторова. – М.: 4 ТЕ Арт, 2011. – 48 с. 134. Ардатская М.Д. Дивертикулярная болезнь толстой кишки: решенные и нерешенные вопросы. Медицинский совет. 2017;(15):68–75.https://doi.org/10.21518/2079-701X-2017-15-68-75. 135. Пилат Т.Л., Безрукавникова Л.М., Коляскина М.М. с соавт. Исследование эффективности детоксицирующего влияния комплексной программы питания DETOX на функциональные показатели организма. Терапия. 2020; 6(2): 156-163. 136. Пилат Т.Л., Кузьмина Л.П., Коляскина М.М., Безрукавникова Л.М. Роль желудочнокишечного тракта в процессах интоксикации и детоксикации организма//Экспериментальная и клиническая гастроэнтерология. 2020. – Вып. 183,№11. – С. 118– 125. 41 137. Пилат Т.Л., Кузьмина Л.П., Измерова И.И. Детоксикационное питание / под ред. Т.Л. Пилат. - М.: ГЭОТАР-Медиа, 2012.-688 с. 1 38. Тутельян В.А., Гаппаров М.М.Г., Батурин А.К. с соавт. Семидневные меню для основных вариантов стандартных диет с использованием блюд оптимизированного состава, применяемых в лечебном питании в медицинских организациях Российской Федерации. М. 2014; 460 с. 139. Пилат Т.Л., Ханферьян Р.А. Специализированные диетические продукты как факторы повышения эффективности фармакотерапии желудочно-кишечных заболеваний//Терапия. - №6. – 2020. – С. 212-218. 140. Пилат Т.Л., Кузьмина Л.П., Лашина Е.Л., Коляскина М.М., Безрукавникова Л.М., Бессонов В.В., Коростелева М.М., Гуревич К.Г., Лагутина Н.П., Ханферьян Р.А. Опыт применения специализированного пищевого продукта диетического лечебного и диетического профилактического питания при воспалительных заболеваниях желудочно-кишечного тракта. Медицинский совет. 2020;(4):107–113. 141. Пилат Т.Л., Лашина Е.Л., Коляскина М.М., Безрукавникова Л.М., Бессонов В.В., Коростелева М.М., Лагутина Н.П., Радыш И.В., Суровцев В.В., Ханферьян Р.А. Эффективность «ЛЕОВИТ GASTRO» при заболеваниях желудочно-кишечного тракта// Ремедиум Поволжье. 2020. – №2(179). – С. 20-21. 142. Пилат Т.Л., Кузьмина Л.П., Гуревич К.Г. с соавт. Методические рекомендации «Нутрициологическая профилактика и реабилитация при заболеваниях желудочно-кишечного тракта – М. – 2019. – 36 с. 143. Lanas A., Ponce J., Bignamini A. et al. One year intermittent rifaximin plus fi bre supplementation vs. fi bre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study. Dig Liver Dis. 2013 Feb; 45(2): 104-109. 144. Festa V., Spila Alegiani S., Chiesara F. et al. Retrospective comparison of long-term tenday/month rifaximin or mesalazine in prevention of relapse in acute diverticulitis. Eur Rev Med Pharmacol Sci. 2017 Mar; 21(6): 1397-1404. 145. Tursi A., Brandimarte G., Daffi nà R. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis. 2002 Jul; 34(7): 510-515. 146. Минушкин О.Н., Кручинина М.А., Алтухова Е.И., Тугова Ю.Е. Дивертикулярная болезнь толстой кишки:диагностика, лечение, профилактика осложнений. Медицинский совет. 2022;16(6):109–115. https://doi.org/10.21518/2079-701X-2022-16-6-109-115 147. Пузанов Д., Пузанова И., Половинкин В. Дивертикулез и дивертикулярная болезнь. Врач. – 2017, №10, С. 11-14.